Moleculin Biotech, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Moleculin Biotech, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-12-31 was $0.00.
- Moleculin Biotech, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-09-30 was $0.00.
- Moleculin Biotech, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-06-30 was $112.00K.
- Moleculin Biotech, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-03-31 was $190.00K.
- Moleculin Biotech, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $302.00K, a 17.03% decline from fiscal 2016.
- Moleculin Biotech, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2016 was $364.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $302.00K 10-K · filed 2019-02-21 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | |
| 2017-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | |
| 2017-03-31 | $190.00K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $364.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |